Pharmaceutical Business Review
Fine & Specialty Chemicals
Anonymous User | Login

Lanxess Swings Into Profit In Q4

Published: 18-Mar-2010

Lanxess, a Germany-based specialty chemicals group, has reported a net profit of EUR14m for the fourth quarter of 2009, compared with a net loss of EUR32m in the same period a year ago.

EBITDA pre exceptionals in the fourth quarter of 2009 was EUR144m, slightly high compared to EUR87m in the fourth quarter of 2008, which was dominated by the effects of the financial crisis.

Lanxess has reported sales of EUR1.39bn, a decrease of 4.8%, compared to EUR1.46bn for the comparable period in 2008.

Revenue for the fourth quarter fell nearly 5% to EUR1.4bn from EUR1.5bn in 2008.

For the full year 2009, Lanxess has posted a net income of EUR40m, compared to EUR183m for the year ago period. Revenue was EUR5.05bn for the 12 months, a decrease of 23.1%, compared to EUR6.57bn for the year ago period.

Lanxess expects the economic landscape to show regional variations in its development in 2010, with Asia showing the significant improvement. The economic climate in Latin America, and in particular Brazil, is expected to brighten. The company expects raw material costs to rise again in 2010.

Axel Heitmann, chairman of the board of management of Lanxess, said: “We therefore expect a significant year-on-year improvement in earnings, even if there is currently no sign of a self-sustaining upswing. Our results in the crisis year show that we passed the stress test.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

USB

Products from Affymetrix ...

CurTec

Producer & Manufacturer of Plastics Packaging ...

Medilingua Translations

The Medical Translation Specialists ...

Valsynthese

Hazardous Chemistry in Safe Hands ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

CaseBase Management

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

SafetyBase Interchange

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

ClinicalBase Trial

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

Reliable Prediction of White Plasma Levels

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Kinetics and Metabolism

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Drug Safety Evaluation

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

Bayer AG

Bayer AG (Bayer) is the management holding company for the Bayer Group. The company car ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

Almac Completes £2 million Client Sponsored Investment Expanding Commercial Sacheting Capacity

Meeting our client partner's commercial need for additional sachet capacity, Almac completes a £2 million investment programme.

Almac's US Headquarters will Address Capacity Demand for Clinical Supplies

Huge increase in storage capacity for ambient, cold storage and controlled drugs.

Quality Control in Medical Translation

Various methods are available to ensure the quality of medical translations – but some are more effective than others.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address